Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peri-operative Adjunctive Probiotics for Recurrent Prosthetic Joint Infection
NCT06636669Phase 4Enrolling by invitation
- Sponsor
- Boston Medical Center
- Start
- Aug 2025
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus rhamnosus GG in prosthetic joint infection (PJI), sponsored by Boston Medical Center. Started Aug 2025; status: enrolling by invitation.
02
Drugs
Lactobacillus rhamnosus GG
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT06636669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06636669.